IDNA
IDNA
About iShares Genomics Immunology and Healthcare ETF
The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.
About iShares Genomics Immunology and Healthcare ETF
The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 MRNA | Moderna, Inc. | 5.03% | 144.58K | $9.69M |
 TWST | Twist Bioscience Corporation | 4.65% | 99.09K | $8.95M |
 RVMD | Revolution Medicines, Inc. | 4.39% | 45.96K | $8.45M |
 INCY | Incyte Corporation | 3.97% | 67.00K | $7.65M |
 VRTX | Vertex Pharmaceuticals Incorporated | 3.83% | 15.35K | $7.37M |
 EXEL | Exelixis, Inc. | 3.79% | 130.16K | $7.29M |
 REGN | Regeneron Pharmaceuticals, Inc. | 3.72% | 10.79K | $7.16M |
 MRK | Merck & Co., Inc. | 3.66% | 56.78K | $7.04M |
 BNTX | BioNTech SE | 3.64% | 77.88K | $7.01M |
 IDYA | IDEAYA Biosciences, Inc. | 3.36% | 178.95K | $6.47M |
 IBRX | ImmunityBio, Inc. | 3.28% | 810.26K | $6.31M |
 RCUS | Arcus Biosciences, Inc. | 2.63% | 180.22K | $5.06M |
 CAI | Caris Life Sciences, Inc. | 2.34% | 263.88K | $4.50M |
 IOVA | Iovance Biotherapeutics, Inc. | 1.75% | 834.70K | $3.37M |
 ABCL | AbCellera Biologics Inc. | 1.71% | 504.62K | $3.29M |
 CRSP | CRISPR Therapeutics AG | 1.62% | 61.72K | $3.12M |
 NUVB | Nuvation Bio Inc. | 1.59% | 531.74K | $3.07M |
 NVAX | Novavax, Inc. | 1.56% | 336.76K | $3.00M |
 VIR | Vir Biotechnology, Inc. | 1.45% | 286.81K | $2.79M |
 KURA | Kura Oncology, Inc. | 1.05% | 184.87K | $2.02M |
SECTOR HOLDINGS
Healthcare
Industrials
Cash & OthersASSET ALLOCATION BY REGION
United States
Germany
France
Japan
Switzerland
Denmark
United Kingdom
China
Canada
Luxembourg
South KoreaSECTOR HOLDINGS
Healthcare Industrials Cash & OthersASSET ALLOCATION BY REGION
United States Germany France Japan Switzerland Denmark United Kingdom China Canada Luxembourg South KoreaHoldings (Top 20)
MRNA
Moderna, Inc.
TWST
Twist Bioscience Corporation
RVMD
Revolution Medicines, Inc.
INCY
Incyte Corporation
VRTX
Vertex Pharmaceuticals Incorporated
EXEL
Exelixis, Inc.
REGN
Regeneron Pharmaceuticals, Inc.
MRK
Merck & Co., Inc.
BNTX
BioNTech SE
IDYA
IDEAYA Biosciences, Inc.
IBRX
ImmunityBio, Inc.
RCUS
Arcus Biosciences, Inc.
CAI
Caris Life Sciences, Inc.
IOVA
Iovance Biotherapeutics, Inc.
ABCL
AbCellera Biologics Inc.
CRSP
CRISPR Therapeutics AG
NUVB
Nuvation Bio Inc.
NVAX
Novavax, Inc.
VIR
Vir Biotechnology, Inc.
KURA
Kura Oncology, Inc.